Targeting the androgen receptor in triple-negative breast cancer: current perspectives

Triple-negative breast cancer (TNBC) is an aggressive subtype associated with frequent recurrence and metastasis. Unlike hormone receptor-positive subtypes, treatment of TNBC is currently limited by the lack of clinically available targeted therapies. Androgen signaling is necessary for normal breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Mina, Alain, Yoder, Rachel, Sharma, Priyanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614778/
https://www.ncbi.nlm.nih.gov/pubmed/29033586
http://dx.doi.org/10.2147/OTT.S126051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614778/
https://www.ncbi.nlm.nih.gov/pubmed/29033586
http://dx.doi.org/10.2147/OTT.S126051

Ejemplares similares